Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
Conditions
- Prostate Carcinoma
- Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Interventions
- PROCEDURE: Computed Tomography
- OTHER: Gallium Ga 68 Gozetotide
- DRUG: Lutetium Lu 177 Vipivotide Tetraxetan
- PROCEDURE: Positron Emission Tomography
- PROCEDURE: PSMA PET Scan
- OTHER: Questionnaire Administration
- PROCEDURE: Single Photon Emission Computed Tomography
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators